SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 36,950
+2,450 (7.10%)
Nov 5, 2026, 3:30 PM KST
SK bioscience Market Cap
SK bioscience has a market cap or net worth of 2.88 trillion as of November 5, 2026. It is the 6,314th most valuable company in the world and the 139th biggest in South Korea. Its market cap has decreased by 38.78% in one year.
Market Cap
2.88T
Enterprise Value
2.86T
Revenue
659.27B
Global Rank
Country Rank
#139 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 18, 2021, SK bioscience's market cap has decreased from 12.93T to 2.88T, a decrease of -77.70%. That is a compound annual growth rate of -23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 2.88T | -23.68% |
| Dec 30, 2025 | 3.78T | -4.31% |
| Dec 30, 2024 | 3.95T | -28.57% |
| Dec 28, 2023 | 5.53T | -2.04% |
| Dec 29, 2022 | 5.64T | -67.21% |
| Dec 30, 2021 | 17.21T | 33.14% |
| Mar 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Epis Holdings | 7.71T |
| SK Biopharmaceuticals | 6.37T |
| HLB Co., Ltd. | 5.38T |
| Peptron | 2.27T |
| LigaChem Biosciences | 2.23T |
| ABL Bio | 2.16T |
| Hugel | 2.05T |
| OliX Pharmaceuticals | 2.04T |